139 related articles for article (PubMed ID: 10823185)
1. Comparative efficacy of fluconazole and amphotericin B in the parenteral treatment of experimental paracoccidioidomycosis in the rat.
Martinez R; Malta MH; Verceze AV; Arantes MR
Mycopathologia; 1999; 146(3):131-4. PubMed ID: 10823185
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of voriconazole in experimental rat paracoccidioidomycosis.
Granzoto DS; Vitali LH; Martinez R
Rev Soc Bras Med Trop; 2013; 46(1):79-83. PubMed ID: 23563830
[TBL] [Abstract][Full Text] [Related]
3. Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis.
Dietze R; Fowler VG; Steiner TS; Pecanha PM; Corey GR
Am J Trop Med Hyg; 1999 May; 60(5):837-9. PubMed ID: 10344661
[TBL] [Abstract][Full Text] [Related]
4. Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis.
Saldanha CA; Garcia MP; Iocca DC; Rebelo LG; Souza AC; Bocca AL; Almeida Santos Mde F; Morais PC; Azevedo RB
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004754. PubMed ID: 27303789
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasiliensis and Paracoccidioides lutzii in a Galleria mellonella model.
de Lacorte Singulani J; Scorzoni L; de Paula E Silva AC; Fusco-Almeida AM; Mendes-Giannini MJ
Int J Antimicrob Agents; 2016 Sep; 48(3):292-7. PubMed ID: 27444116
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
[TBL] [Abstract][Full Text] [Related]
7. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
Amaral AC; Bocca AL; Ribeiro AM; Nunes J; Peixoto DL; Simioni AR; Primo FL; Lacava ZG; Bentes R; Titze-de-Almeida R; Tedesco AC; Morais PC; Felipe MS
J Antimicrob Chemother; 2009 Mar; 63(3):526-33. PubMed ID: 19151037
[TBL] [Abstract][Full Text] [Related]
8. Alternatives to amphotericin B for Candida rugosa infection.
Hernandez S; Gonzalez GM; McCarthy DI; Colombo AL; Najvar LK; Bocanegera R; Graybill JR
J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
Bannatyne RM; Cheng PC; Fong IW
Infection; 1992; 20(3):168-70. PubMed ID: 1644494
[TBL] [Abstract][Full Text] [Related]
10. Immunological features of chronic adult paracoccidioidomycosis: report of a case treated with fluconazole.
Pereiro M; Pereiro M; García García A; Toribio J
Acta Derm Venereol; 1996 Jan; 76(1):84-5. PubMed ID: 8721509
[No Abstract] [Full Text] [Related]
11. The combined use of Paracoccidioides brasiliensis Pb40 and Pb27 recombinant proteins enhances chemotherapy effects in experimental paracoccidioidomycosis.
Fernandes VC; Martins EM; Boeloni JN; Coitinho JB; Serakides R; Goes AM
Microbes Infect; 2011 Nov; 13(12-13):1062-72. PubMed ID: 21726659
[TBL] [Abstract][Full Text] [Related]
12. [In vitro sensitivity of Paracoccidioides brasiliensis to systemically used antifungal agents].
Rodero L; Canteros CE; Rivas C; Lee W; Davel G
Rev Argent Microbiol; 1999; 31(2):78-81. PubMed ID: 10425663
[TBL] [Abstract][Full Text] [Related]
13. In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.
Hahn RC; Fontes CJ; Batista RD; Hamdan JS
J Clin Microbiol; 2002 Aug; 40(8):2828-31. PubMed ID: 12149337
[TBL] [Abstract][Full Text] [Related]
14. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
[TBL] [Abstract][Full Text] [Related]
16. Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis.
Fernandes VC; Martins EM; Boeloni JN; Coitinho JB; Serakides R; Goes AM
PLoS One; 2011 Mar; 6(3):e17885. PubMed ID: 21423771
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK
Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM
J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
[TBL] [Abstract][Full Text] [Related]
19. Paracoccidioidomycosis.
Marques SA
Clin Dermatol; 2012; 30(6):610-5. PubMed ID: 23068148
[TBL] [Abstract][Full Text] [Related]
20. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
